Making Sure the Low Risk MDS Patient Remains Low Risk: Developing Effective Individualized Treatment Strategies

You need to be logged in to continue. Please Log In or Register using the box at the top right of this page.

Release Date: April 26, 2016
Expiration Date: April 26, 2017

Expected time to complete this activity as designed: 30 minutes
There are no fees for participating in or receiving credit for this online activity.

Program Overview

Many patients diagnosed with low-risk MDS eventually progress to higher-risk disease. Join Dr. Douglas Smith as he discusses individualizing therapy to minimize the development of higher-risk MDS. Through an analysis of options for patient-centered treatment in low-risk MDS patients, both with and without 5Q deletion, Dr. Smith reviews the current standard of care and therapeutic options available in practice today.

Target Audience

This activity is designed for physicians, pharmacists, physician assistants, and other health care professionals who have an interest in enhancing their clinical skills in myelodysplastic syndromes.

Learning Objectives

Upon completion of this educational activity, participants should be able to:

  • Describe the importance of individualized treatment strategies in MDS patients, focusing on the impact of such strategies on disease progression and transformation
  • Outline the role of growth factors, immunosuppression, IMiDs and hypomethylating agents in lower-risk MDS

Agenda

Making Sure the Low Risk MDS Patient Remains Low Risk: Developing Effective Individualized Treatment Strategies – B. Douglas Smith, MD

Instructions for Participation and Credit

This activity is eligible for credit through April 26, 2017. After this date, this activity will expire and no further credit will be awarded.

  1. Read the target audience, learning objectives, and faculty disclosures.
  2. You may be asked to complete a short pre-test before accessing the educational content. This must be completed in order to move forward in the activity.
  3. Complete the educational content as designed.
  4. Complete the post-test. To receive a certificate, you must receive a passing score of 70%.
  5. Complete the activity evaluation survey to provide feedback and information useful for future programming.
  6. Certificates for CME credit may be printed immediately after successfully completing the post-test and activity evaluation. Pharmacist credit will be uploaded to CPE Monitor 4 weeks following receipt of a completed, qualified form.

Faculty Biography

B. Douglas Smith, MD
Professor of Oncology
Division of Hematologic Malignancies
Johns Hopkins University School of Medicine
Baltimore, Maryland

Dr. B. Douglas Smith received his medical degree from the Medical College of Pennsylvania in Philadelphia, followed by an internship, residency, and chief residency in internal medicine at the University of Rochester’s Strong Memorial Hospital. Dr. Smith went on to complete his oncology fellowship at The Johns Hopkins University School of Medicine in Baltimore, Maryland, where he joined the faculty at Johns Hopkins and he is now Professor of Oncology in the Division of Hematologic Malignancies.

Dr. Smith’s research focuses on taking new and promising laboratory insights and developing them into biology-based treatment approaches for patients with myeloid malignancies. He has focused on the clinical development of differentiation-based treatments, signal transduction and targeted drug development, and immunotherapy using vaccine strategies. His trials carry a common theme of targeting leukemia stem cells.

Clinically, Dr. Smith manages an active clinic for patients with myeloid malignancies, including acute and chronic myeloid leukemias, and myelodysplastic syndromes. He is recognized as a national leader in these areas and serves on the NCCN Guideline Panel for both AML and CML. Dr. Smith also supports the Kimmel Cancer Center at Johns Hopkins by co-chairing one of the School of Medicine’s Institutional Review Boards.

Accreditation

MediCom CME CREDIT
Accreditation Statement: MediCom Worldwide, Inc. is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Designation Statement: MediCom Worldwide, Inc. designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
ACPE CPE CREDIT
MediCom Worldwide, Inc. is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This activity is acceptable for 0.5 contact hours of Continuing Education Credit. Universal Activity Number: 827-0000-16-073-H01-P. Knowledge-based CPE activity.

In order for CPE Monitor to authenticate credit, pharmacists/technicians must provide their e-Profile ID number from NABP and date of birth (in MMDD format) when registering for a CPE program. Please make sure to provide this information in your Member Profile accessed through the Member Center on the home page of this site.

Disclosure

As an organization accredited by the Accreditation Council for Continuing Medical Education (ACCME), Accreditation Council for Pharmacy Education (ACPE) and California State Board of Registered Nursing, MediCom Worldwide, Inc. requires everyone who is a position to control the content of an educational activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines “relevant financial relationships” as financial relationships in any amount, occurring within the past 12 months, including financial relationships of a spouse or life partner, that could create a conflict of interest. Accordingly, the following disclosures were made.

Faculty Disclosure

Dr. B. Douglas Smith has received honoraria as a consultant from Celgene Corporation.

Planning Committee Disclosures

The individuals listed below from MediCom Worldwide, Inc. reported the following for this activity: Joan Meyer, RN, MHA, Executive Director, has no relevant financial relationships.

Peer Reviewer Disclosure

In accordance with MediCom Worldwide, Inc. policy, all content is independently peer reviewed for balance, objectivity and commercial bias. The peer reviewers have no relevant financial relationships to disclose.

Off-Label Disclosures/Investigational Disclosures

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings. Further, attendees/participants should appraise the information presented critically and are encouraged to consult appropriate resources for any product or device mentioned in this program.

Dr. Smith has indicated that he does not intend to discuss off-label uses of drugs, mechanical devices, biologics or diagnostics approved by the US Food and Drug Administration (FDA) for use in the US.

Dr. Smith has indicated that he does intend to discuss investigational drugs, mechanical devices, biologics or diagnostics not approved by the FDA for use in the US.

Hardware/Software/Internet Requirements

MediCom Worldwide, Inc. requires Internet Explorer® version 9.0 or higher, the latest version of Google Chrome, or the latest version of Safari, a computer running Windows® Vista, Windows® 7, or Mac OS X, 512MB of RAM or greater, 1.5 GHZ or faster processor, and a screen resolution of 1024x768 or higher. Certain educational activities may require additional software to view. These activities will be marked with the information and/or links to the required software. That software may include Adobe® Flash® Player, Adobe® Acrobat®, Windows Media® Player, and/or Microsoft® Silverlight™.

If you have any questions or concerns regarding this activity, please contact MediCom Worldwide, Inc. at 1-800-408-4242 or email us at lisa@medicaled.com.

Provided by MediCom Worldwide, Inc.
This activity is supported by an educational grant from Celgene Corporation.

©2016 MediCom Worldwide, Inc., 101 Washington St., Morrisville, PA 19067, 800-408-4242.
No portion of this material may be copied or duplicated without the expressed permission of MediCom Worldwide, Inc.

You need to be logged in to continue. Please Log In or Register using the box at the top right of this page.

Managing MDS would like to recognize and thank Celgene Corporation for their educational support of ManagingMDS.com

©2017 MediCom Worldwide, Inc. All rights reserved